Related Experiment Video
Updated: Jan 6, 2026

Author Spotlight: Expression and Purification of Human Solute Carrier Transporters Using Codon-Optimized Genes
Published on: September 29, 2023
Pharmacological Mechanisms of SLC6 Neurotransmitter Transporter Inhibition
Dipanjana Bandyopadhyay1, Smruti Ranjan Nayak1, Aravind Penmatsa2
1Molecular Biophysics Unit, Indian Institute of Science, Bangalore, India.
Abstract:
Solute carrier 6 family members comprise of neurotransmitter sodium symporters that are the transporters primarily involved in the reuptake of released neurotransmitters from the synaptic space. The family includes structurally related transporters involved in biogenic amine and amino acid neurotransmitter uptake and is a well-known therapeutic target for several classes of inhibitors for the treatment of ailments ranging from depression, pain, addiction, seizures and anxiety. Inhibition of NSS transporters can work either through competitive inhibition or through allosteric inhibition at diverse sites that target multiple conformational states of the transporters. This chapter explores the diverse inhibition strategies observed with numerous inhibitors that target this class of transporters and potential for improvements in inhibition strategies.
Related Concept Videos
Drugs Affecting Neurotransmitter Release or Uptake
Neurochemical Transmission: Sites of Drug Action
Drugs Affecting Neurotransmitter Synthesis
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
Membrane Transporters
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

